Integrated BioPharma's total assets for Q3 2025 were $25.66M, a decrease of -0.02% from the previous quarter. INBP total liabilities were $5.27M for the fiscal quarter, a -11.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.